Total Payments
$4,795
2024 Payments
$67.79
Companies
9
Transactions
19
Medicare Patients
183
Medicare Billing
$21,513
Payment Breakdown by Category
Research$3,012 (62.8%)
Other$1,000.00 (20.9%)
Food & Beverage$719.32 (15.0%)
Travel$32.17 (0.7%)
Education$31.50 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3,012 | 2 | 62.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,000 | 1 | 20.9% |
| Food and Beverage | $719.32 | 13 | 15.0% |
| Travel and Lodging | $32.17 | 2 | 0.7% |
| Education | $31.50 | 1 | 0.7% |
Payments by Type
Research
$3,012
2 transactions
General
$1,783
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $3,067 | 3 | $0 (2018) |
| Seattle Genetics, Inc. | $1,330 | 8 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $114.41 | 1 | $0 (2017) |
| Genentech USA, Inc. | $102.60 | 1 | $0 (2018) |
| AbbVie, Inc. | $87.18 | 1 | $0 (2019) |
| Abbott Laboratories | $43.20 | 2 | $0 (2024) |
| Chiesi USA, Inc. | $24.59 | 1 | $0 (2024) |
| Midatech Pharma US Inc | $14.85 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $11.94 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.79 | 3 | Abbott Laboratories ($43.20) |
| 2019 | $87.18 | 1 | AbbVie, Inc. ($87.18) |
| 2018 | $2,826 | 7 | Celgene Corporation ($1,579) |
| 2017 | $1,814 | 8 | Celgene Corporation ($1,488) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Vascular | ||||||
| 09/24/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $24.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Vascular | ||||||
| 12/07/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $87.18 | General |
| 10/20/2018 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $102.60 | General |
| Category: BioOncology | ||||||
| 10/18/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $54.67 | General |
| Category: Hematology / Oncology | ||||||
| 03/06/2018 | Seattle Genetics, Inc. | Adcetris (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 03/06/2018 | Seattle Genetics, Inc. | Adcetris (Biological) | Food and Beverage | In-kind items and services | $112.43 | General |
| Category: Oncology | ||||||
| 03/06/2018 | Seattle Genetics, Inc. | Adcetris (Biological) | Travel and Lodging | In-kind items and services | $20.17 | General |
| Category: Oncology | ||||||
| 03/06/2018 | Seattle Genetics, Inc. | Adcetris (Biological) | Travel and Lodging | In-kind items and services | $12.00 | General |
| Category: Oncology | ||||||
| 03/01/2018 | Celgene Corporation | CC-122 (Drug) | — | In-kind items and services | $1,524.00 | Research |
| Study: CC-122-DLBCL-001 - A Phase 1B, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma | ||||||
| 12/09/2017 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $97.70 | General |
| Category: Not Applicable | ||||||
| 10/17/2017 | Midatech Pharma US Inc | Gelclair (Device) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Oncology | ||||||
| 09/29/2017 | Seattle Genetics, Inc. | SGN35 (Biological) | Education | In-kind items and services | $31.50 | General |
| Category: Not Applicable | ||||||
| 09/13/2017 | Actelion Pharmaceuticals US, Inc. | VALCHLOR MECHLORETHAMINE (Drug) | Food and Beverage | In-kind items and services | $114.41 | General |
| Category: CANCER | ||||||
| 08/31/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/24/2017 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: Not Applicable | ||||||
| 08/02/2017 | Celgene Corporation | CC-122 (Drug) | — | In-kind items and services | $1,488.00 | Research |
| Study: CC-122-DLBCL-001 | ||||||
| 04/03/2017 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Not Applicable | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CC-122-DLBCL-001 - A Phase 1B, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma | Celgene Corporation | $1,524 | 1 |
| CC-122-DLBCL-001 | Celgene Corporation | $1,488 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 6 | 183 | 321 | $48,709 | $21,513 |
Total Patients
183
Total Services
321
Medicare Billing
$21,513
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 65 | 140 | $17,577 | $8,113 | 46.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 28 | 64 | $11,215 | $5,773 | 51.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 38 | $6,080 | $2,386 | 39.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 18 | $5,436 | $2,109 | 38.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 22 | 22 | $5,901 | $1,734 | 29.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 33 | 39 | $2,500 | $1,399 | 55.9% |
About Dr. Jason Kaplan, MD
Dr. Jason Kaplan, MD is a Hematology healthcare provider based in Evanston, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669590873.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Kaplan, MD has received a total of $4,795 in payments from pharmaceutical and medical device companies, with $67.79 received in 2024. These payments were reported across 19 transactions from 9 companies. The most common payment nature is "" ($3,012).
As a Medicare-enrolled provider, Kaplan has provided services to 183 Medicare beneficiaries, totaling 321 services with total Medicare billing of $21,513. Data is available for 1 year (2020–2020), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Location Evanston, IL
- Active Since 03/26/2007
- Last Updated 10/29/2019
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1669590873
Products in Payments
- CC-122 (Drug) $3,012
- Adcetris (Biological) $1,145
- ADCETRIS (Biological) $153.45
- VALCHLOR MECHLORETHAMINE (Drug) $114.41
- GAZYVA (Biological) $102.60
- Revlimid (Drug) $54.67
- SGN35 (Biological) $31.50
- KENGREAL (Drug) $24.59
- PERCLOSE PROSTYLE (Device) $23.33
- MITRACLIP (Device) $19.87
- Gelclair (Device) $14.85
- BRILINTA (Drug) $11.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Evanston
David Grinblatt, Md, MD
Hematology — Payments: $279,802
Hematology $279,802
Dr. Javed Imam, M.d, M.D
Hematology — Payments: $5,970
Hematology $5,970
Lynne Kaminer, Md, MD
Hematology — Payments: $2,102
Hematology $2,102
Saad Arain, M.d, M.D
Hematology — Payments: $36.66
Hematology $36.66
Jennifer Obel, Md, MD
Hematology
Hematology